Patents by Inventor Mark Bock

Mark Bock has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N-biphenylmethyl aminocycloalkanecarboxamide derivatives
    Publication number: 20050085667
    Abstract: N-Biphenyl(substituted methyl) aminocycloalkanecarboxamide derivatives are bradykinin B1 antagonists or inverse agonists useful in the treatment or prevention of symptoms such as pain and inflammation associated with the bradykinin B1 pathway.
    Type: Application
    Filed: February 4, 2003
    Publication date: April 21, 2005
    Inventors: Michael Wood, Neville Anthony, Mark Bock, Dong-Mei Feng, Scott Kuduk, Dai-Shi Su, Jenny Wai
  • 2-Quinoxalinone derivatives as bradykinin antagonists and novel compounds
    Publication number: 20050020591
    Abstract: 2-Quinoxalinone derivatives are bradykinin B1 antagonists or inverse agonists useful in the treatment or prevention of symptoms such as pain and inflammation associated with the bradykinin B1 pathway.
    Type: Application
    Filed: July 7, 2003
    Publication date: January 27, 2005
    Inventors: Dai-Shi Su, Mark Bock
  • Cholecystokinin antagonists
    Patent number: 5218115
    Abstract: Benzodiazepine analogs of the formula: ##STR1## are disclosed which are antagonists of gastrin and cholecystokinin (CCK).
    Type: Grant
    Filed: March 10, 1992
    Date of Patent: June 8, 1993
    Assignee: Merck & Co., Inc.
    Inventors: Mark Bock, Roger M. Freidinger